Raymond James & Associates’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $66.1K | Buy |
+11,631
| New | +$66.1K | ﹤0.01% | 3779 |
|
|
2024
Q1 | – | Sell |
-12,129
| Closed | -$113K | – | 3876 |
|
|
2023
Q4 | $113K | Sell |
12,129
-500
| -4% | -$4.66K | ﹤0.01% | 3601 |
|
|
2023
Q3 | $82.7K | Sell |
12,629
-950
| -7% | -$6.22K | ﹤0.01% | 3598 |
|
|
2023
Q2 | $110K | Buy |
13,579
+384
| +3% | +$3.12K | ﹤0.01% | 3566 |
|
|
2023
Q1 | $113K | Buy |
+13,195
| New | +$113K | ﹤0.01% | 3585 |
|